Evidence map›Paper›PMID 29063233›Full record

GuidelineWiener klinische Wochenschrift2017

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).

Thomas Reiberger, Andreas Püspök, Maria Schoder, Franziska Baumann-Durchschein, Theresa Bucsics, Christian Datz, Werner Dolak, Arnulf Ferlitsch, Armin Finkenstedt, Ivo Graziadei and 15 more

3 registry-linked trialsOpen access · hybridAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Wiener klinische Wochenschrift, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 75 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 4 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04786743 nacompletednot on this mapstarted 2021, after this paper: background citation

Timing of Endoscopic Intervention in Patients With Cirrhosis With Acute Variceal Upper Gastrointestinal Hemorrhage (TEACH Trial): a Randomized Clinical Trial

TypeinterventionalSponsorJinling Hospital, ChinaRan2021 to 2026Enrolled412ConditionsAcute Upper Gastrointestinal Hemorrhage, Cirrhosis, Varice Bleed, Gastroesophageal VaricesArmsendoscopic intervention
NCT04932200 unknown statusnot on this mapstarted 2021, after this paper: background citation

A Prospective Multicenter Cohort Study on the Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis

TypeobservationalSponsorRenmin Hospital of Wuhan UniversityRan2021 to 2022Enrolled608ConditionsLiver Cirrhosis, Portal Hypertension, Esophageal Varix Bleeding
NCT06325436 unknown statusnot on this mapstarted 2024, after this paper: background citation

Accuracy of Simple Objective Scores in Prediction of Short-Term Outcome Among Cirrhotic Patients With Variceal Bleeding

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled85ConditionsVariceal Hemorrhage
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 4 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Guideline
  2. [Chinese guidelines for clinical diagnosis, treatment, and management of cirrhosis (2025)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  3. Guideline
  4. [Guidelines on the management of ascites in cirrhosis (2023 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Guideline
  5. Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 1 institution in 1 country.

Thomas ReibergerDivision of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. thomas.reiberger@meduniwien.ac.at.ORCID http://orcid.org/0000-0002-4590-3583
Andreas Püspök
Maria Schoder
Franziska Baumann-Durchschein
Theresa Bucsics
Christian Datz
Werner Dolak
Arnulf Ferlitsch
Armin Finkenstedt
Ivo Graziadei
Stephanie Hametner
Franz Karnel
Elisabeth Krones
Andreas Maieron
Mattias Mandorfer
Markus Peck-Radosavljevic
Florian Rainer
Philipp Schwabl
Vanessa Stadlbauer
Rudolf Stauber
Herbert Tilg
Michael Trauner
Heinz Zoller
Rainer Schöfl
Peter Fickert
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Billroth III guidelines were developed during a consensus meeting of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of Interventional Radiology (ÖGIR) held on 18 February 2017 in Vienna. Based on international guidelines and considering recent landmark studies, the Billroth III recommendations aim to help physicians in guiding diagnostic and therapeutic strategies in patients with portal hypertension.

Indexed as

AustriaCarbazolesCarvedilolComorbidityEarly Medical InterventionEsophageal and Gastric VaricesGastrointestinal HemorrhageHumansHypertension, PortalLiver CirrhosisMass ScreeningPropanolaminesPropranololRandomized Controlled Trials as TopicTimololCarbazolesCarvedilolPropanolaminesPropranololTimololAscitesAustriaBillrothCirrhosisGuidelinesPortal hypertensionTIPSVarices

Identifiers

PMID29063233
PMCPMC5674135
OpenAlexW2765787758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.